Clinical Trials Logo

Tennis Elbow clinical trials

View clinical trials related to Tennis Elbow.

Filter by:
  • Not yet recruiting  
  • « Prev · Page 2

NCT ID: NCT03300531 Not yet recruiting - Rotator Cuff Tear Clinical Trials

Impact of Autologous Pure Platelet-rich Plasma in the Treatment of Tendon Disease

Start date: December 1, 2017
Phase: Phase 2
Study type: Interventional

This is a randomized parallel controlled double-blind phase 2 clinical study.All subjects are recruited from the patients of rotator cuff tear, lateral epicondylitis or chronic achilles tendonitis. Patients will be randomly divided into three groups. Autologous pure platlet-rich plasma (P-PRP) and platlet-rich plasma (PRP) are purified from the peripheral blood .Patients of case groups will receive P-PRP or PRP injection once a week for three times while the control group received the same dose compound betamethasone injection. Follow up visit will occur at 1 month,3 months, 6 months,12 months after the last injection. Clinical quantitative assessment will measure by the visual analogue scale(VAS). The secondary outcomes are the constant-murley score(CMS) and the rating scale of the American shoulder and elbow surgeons(ASES) and the disability of arm shoulder and hand(DASH). The objective evaluation methods is that the examination of MRI or ultrasound were accomplished before the first injection and at 6 and 12 months afterwards.

NCT ID: NCT03279796 Not yet recruiting - Rotator Cuff Tear Clinical Trials

Treatment of Tendon Disease Using Autologous Adipose-derived Mesenchymal Stem Cells

Start date: October 1, 2018
Phase: Phase 2
Study type: Interventional

This study was a single-center, randomized, single-blind clinical trial. We plan to include 100 patients who met exclusion criteria of rotator cuff and lateral epicondylosis (tennis elbow) respectively by MRT or ultrasonography. The patients will be randomly divided into two groups. Adipose mesenchymal stem cells will be isolated from adipose tissue, cultured and then transplanted back to the tendon injury site by multiple point injection. 1*10^6 cells as an unit. Patients in the experiment group will be injected into an unit of adipose mesenchymal stem cells (1*10^6/10kg) while the control group received the same dose compound betamethasone injection. Follow up visit for all patients will occur at 1,3,6 and 12 months after the first injection. Clinical quantitative assessment will measure by the visual analogue scale(VAS). The secondary outcomes are the constant-murley score(CMS) and the rating scale of the American shoulder and elbow surgeons(ASES) and the disability of arm shoulder and hand(DASH). The objective evaluation methods is that the examination of MRI or ultrasound were accomplished before the first injection and at 6 and 12 months afterwards.

NCT ID: NCT00447928 Not yet recruiting - Tendonitis Clinical Trials

Phase II Dose-Ranging Study of OrthoDerm Patch for Patients With Tennis Elbow

Start date: April 2007
Phase: Phase 2
Study type: Interventional

The purpose of the study is to evaluate the effectiveness and safety of the use of low-dose nitroglycerin transdermal patches to treat pain and function in chronic tennis elbow.